A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects

NCT04577885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SHR2554 and Rifampin

Sponsor

Jiangsu HengRui Medicine Co., Ltd.